165 related articles for article (PubMed ID: 37005667)
21. TIPE2 acts as a tumor suppressor and correlates with tumor microenvironment immunity in epithelial ovarian cancer.
Xu S; Gao X; Qiu J; Hong F; Gao F; Wang X; Zhang S
Aging (Albany NY); 2023 Feb; 15(4):1052-1073. PubMed ID: 36801818
[TBL] [Abstract][Full Text] [Related]
22. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
Pi Y; Sun F; Zhang Z; Liu X; Lou G
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
[No Abstract] [Full Text] [Related]
23. A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer.
Huang Q; Lv Q; Tang W; Pan Y; Xing Y; He M; Wu H; Huang J; Huang C; Lan H; Chen J; Xiao G
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10561-10583. PubMed ID: 37286734
[TBL] [Abstract][Full Text] [Related]
24. A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer.
Zhang M; Liu Y; Liu Y; Hou S; Li H; Ma Y; Wang C; Chen X
Front Genet; 2022; 13():815082. PubMed ID: 35664304
[No Abstract] [Full Text] [Related]
25. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
26. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
27. LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer.
Zhu X; You S; Du X; Song K; Lv T; Zhao H; Yao Q
BMC Med Genomics; 2023 Jan; 16(1):10. PubMed ID: 36653841
[TBL] [Abstract][Full Text] [Related]
28. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
Li W; Ma JA; Sheng X; Xiao C
World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
30. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
31. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
32. Association between tumor mutation burden and immune infiltration in ovarian cancer.
Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
[TBL] [Abstract][Full Text] [Related]
33. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
34. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
36. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
37. The Effect of PTCH1 on Ovarian Cancer Cell Proliferation and Apoptosis.
Zheng F; Xiao X; Wang C
Cancer Biother Radiopharm; 2019 Mar; 34(2):103-109. PubMed ID: 30523702
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
39. Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy.
Ma C; Zheng Q; Wang Y; Li G; Zhao M; Sun Z
Aging (Albany NY); 2023 Aug; 15(17):8664-8691. PubMed ID: 37606975
[TBL] [Abstract][Full Text] [Related]
40. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
